VREOF 8-K 2026-08-11

Vireo Growth Inc. (VREOF) 8-K dated 2026-08-11 — accession 0001104659-26-093723.

Vireo Growth Inc. (VREOF) is a drug manufacturers - specialty & generic company listed on OTCQX.

Vireo Growth Inc. filed a 8-K on 2026-08-11. Accession 0001104659-26-093723.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported VREOF revenue for 2025-12-31 was $268.8M. Net income was -$68.1M. Revenue was up 170.4% from 2024-12-31 to 2025-12-31. VREOF currently screens at market cap $773.5M.

Not investment advice. The VREOF SEC hub lists recent forms. The stock page is the research view.